Analyst Comment Tymlos outperforms teriparatide in real-world fracture analysis The study supported Tymlos’ value in reducing fracture risk in the osteoporosis space. GlobalData Healthcare
Analyst Comment Measles cases continue to rise in US amid lagging vaccination rates GlobalData Healthcare
Analyst Comment Nanoscope Therapeutics exhibits positive top-line Phase IIb results for MCO-010 GlobalData Healthcare
Analyst Comment CRISPR drug licensing deals secure $21bn in top three therapy areas over five years GlobalData Healthcare
Analyst Comment Cheap drugs, inspections, and a future war in Europe – what’s driving drug shortages? GlobalData Healthcare
Analyst Comment Experts flag concerns with drug compliance in osteoporosis landscape GlobalData Healthcare
Analyst Comment CRISPR-based assay could revolutionise diagnosis of NTM infections GlobalData Healthcare
Analyst Comment IO360: first allogeneic dual CAR-T shows promise in B-cell Non-Hodgkin lymphoma GlobalData Healthcare
Analyst Comment IO360: Motixafortide shows Phase II efficacy in first-line pancreatic cancer GlobalData Healthcare
Analyst Comment PD-1 inhibitors and systemic oncolytic viral immunotherapies under the spotlight at IO360 GlobalData Healthcare
Analyst Comment BIOSECURE Act could impact WuXi-manufactured drugs for the US market GlobalData Healthcare
Analyst Comment Eli Lilly’s partnership with Amazon to boost presence in diabetes and obesity markets GlobalData Healthcare
Analyst Comment AD/PD 2024: BioVie’s novel NE3107 shows promise but confirmatory trial needed GlobalData Healthcare
Analyst Comment AD/PD 2024: TauRx’s HMTM promising despite lacking primary endpoint data GlobalData Healthcare
Analyst Comment Innovent’s ROS1 TKI is one step closer to winning the Chinese NSCLC market GlobalData Healthcare
Analyst Comment Oncology emerges as dominant therapy area for CRISPR technology GlobalData Healthcare
Analyst Comment Market cap upturn for top 20 biopharma companies with obesity drug successes in 2023 GlobalData Healthcare
Analyst Comment The health risks of ultra-processed foods (UPFs) are worse than we think GlobalData Thematic Intelligence
Analyst Comment Shifting the paradigm – novel approaches to amyotrophic lateral sclerosis therapy GlobalData Healthcare
Analyst Comment Biogen discontinues Aduhelm to focus on Leqembi for Alzheimer’s disease GlobalData Healthcare
Analyst Comment Beacon Therapeutics unveils promising interim results for gene therapy AGTC-501 GlobalData Healthcare
Analyst Comment Will smart tech revolutionise drug delivery for ulcerative colitis patients? GlobalData Healthcare
Analyst Comment Japan’s FY 2024 pricing reform expected to favour new listed innovative drugs Chia Lin